18. Labrada Rodríguez YH. Algunas consideraciones sobre la fisiopatología del glaucoma. Rev. Cubana de Oftalmol. 2007;20(2). [citado 05 de abril de 2008]. Disponible en:
http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S086421762007000200018&lng=es&nrm=iso.
19. Warpeha KM, Xu W, Liu L, Charles IG, Patterson CC, Ah-fat F, Harding S, Hart PM, Chakravarthy U, Hughes AE. Genotyping and functional analysis of a polymorphic (CCTTT)(n) repeat of NOS2A in diabetic retinopathy. FASEB J 1999; 13: 1825-1832.
20. Asensio Sánchez VM, Sánchez JC, Aguirre Gómez B, Villarreal M. HLA: factor de riesgo en la retinopatía diabética. St Ophthal 2000; 19: 19-21.
21. Vorwerk CK, Naskar R, Schuettauf F, Quinto K, Zurakowski D, Gochenauer G, Robinson MB, Mackler SA, Dreyer EB. Depression of retinal glutamate transporter function leads to elevated intravitreal glutamate levels and ganglion cell death. Invest Ophthalmol Vis Sci 2007; 41: 3615-3621.
22. Li Q, Puro DG. Diabetes-induced dysfunction of the glutamate transporter in retinal Müller cells. Invest Ophthalmol Vis Sci 2002; 43: 3109-3116.
23. Ambati J, Chalam KV, Chawla DK, D´Angio CT, Guillet EG, Rose SJ, Vanderlinde RE, Ambati BK. Elevated gamma-aminobutyric acid, glutamate, and vascular endotelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 1997; 115: 1161-1166.
24. Lahdenranta J, Pasqualini R, Schlingemann RO, Hagedorn M, Stallcup WB, Bucana CD, Sidman RL, Arap W. An anti-angiogenic state in mice and humans with retinal photoreceptor cell degeneration. Proc Natl Acad Sci USA 2001; 98: 10368-10373.
25. Krakchuck EA. Free-radical oxidation in the pathogenesis of the eye diseases. Vestn Oftalmol. 2004; 120(5):48-51.